IL103471A0 - Compositions and methods for therapy and prevention of cancer,aids and anemia - Google Patents
Compositions and methods for therapy and prevention of cancer,aids and anemiaInfo
- Publication number
- IL103471A0 IL103471A0 IL103471A IL10347192A IL103471A0 IL 103471 A0 IL103471 A0 IL 103471A0 IL 103471 A IL103471 A IL 103471A IL 10347192 A IL10347192 A IL 10347192A IL 103471 A0 IL103471 A0 IL 103471A0
- Authority
- IL
- Israel
- Prior art keywords
- anemia
- aids
- cancer
- therapy
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/779,744 US6037376A (en) | 1991-10-21 | 1991-10-21 | Methods for therapy of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL103471A0 true IL103471A0 (en) | 1993-03-15 |
Family
ID=25117401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL103471A IL103471A0 (en) | 1991-10-21 | 1992-10-20 | Compositions and methods for therapy and prevention of cancer,aids and anemia |
Country Status (9)
Country | Link |
---|---|
US (2) | US6037376A (xx) |
EP (4) | EP1108428A3 (xx) |
AT (3) | ATE213409T1 (xx) |
DE (3) | DE69232426T2 (xx) |
DK (1) | DK1484059T3 (xx) |
ES (2) | ES2171400T3 (xx) |
HK (1) | HK1067551A1 (xx) |
IL (1) | IL103471A0 (xx) |
NZ (1) | NZ244850A (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE448194T1 (de) | 2000-08-29 | 2009-11-15 | Biocon Ltd | Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts |
US7090839B2 (en) | 2000-09-01 | 2006-08-15 | Hidden Valley, N.V. | Method of treatment of human immunodeficiency diseases |
US6538030B2 (en) | 2000-09-20 | 2003-03-25 | Yih-Lin Chung | Treating radiation fibrosis |
US6372938B1 (en) | 2001-05-21 | 2002-04-16 | Stanislaw R. Burzynski | Synthesis of 4-phenylbutyric acid |
US8048924B2 (en) * | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
EP1291015A1 (en) * | 2001-09-10 | 2003-03-12 | Lunamed AG | Dosage forms having prolonged active ingredient release |
WO2003082193A2 (en) * | 2002-03-26 | 2003-10-09 | Eastern Virginia Medical School | Suramin and derivatives thereof as topical microbicide and contraceptive |
US20040229948A1 (en) * | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
US8163764B2 (en) * | 2002-04-26 | 2012-04-24 | Asan Laboratories Company (Cayman) Limited | Skincare methods |
US6809118B2 (en) * | 2002-07-25 | 2004-10-26 | Yih-Lin Chung | Methods for therapy of radiation cutaneous syndrome |
US20060275370A1 (en) * | 2002-07-25 | 2006-12-07 | Yih-Lin Chung | Method and compositions for treatment of epithelial damage |
US8946295B2 (en) | 2002-07-25 | 2015-02-03 | Sunny Pharmtech Inc. | Histone hyperacetylating agents for promoting wound healing and preventing scar formation |
US8846039B2 (en) * | 2002-04-26 | 2014-09-30 | Asan Laboratories Company (Cayman), Limited | Method for ameliorating pruritus |
US20040152784A1 (en) * | 2002-07-23 | 2004-08-05 | Special Products Limited | Pharmaceutical composition and method for treatment of a urea cycle deficiency or sickle-cell anaemia |
ATE400261T1 (de) * | 2004-03-11 | 2008-07-15 | Asan Lab Company Cayman Ltd | Verwendung von histone deacetylase hemmern zur steigerung der therapeutischen wirkung in der radiotherapie und chemotherapie |
WO2006014549A2 (en) * | 2004-07-07 | 2006-02-09 | Nobex Corporation | Synthesis of azo bonded immunoregulatory compounds |
EP1799759A1 (en) * | 2004-08-30 | 2007-06-27 | Lunamed Inc. | 4-phenylbutyric acid controlled-release formulations for therapeutic use |
US20060205818A1 (en) * | 2005-03-08 | 2006-09-14 | Burzynski Stanislaw R | Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives |
US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
EP1924245A2 (en) * | 2005-08-19 | 2008-05-28 | Government of the United States of America, Represented by the Secretary, Department of Health and Human Services | Topical formulations of histone deacetylase inhibitors and methods of using the same |
US20090054497A1 (en) * | 2007-08-21 | 2009-02-26 | Nawaz Ahmad | Methods for attaining enhanced sexual wellness using anhydrous compositions |
US20090054498A1 (en) * | 2007-08-21 | 2009-02-26 | Nawaz Ahmad | Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness |
US20110301153A1 (en) * | 2008-11-17 | 2011-12-08 | The Trustees Of The University Of Pennsylvania | Methods of treating cancer |
JP2020520935A (ja) * | 2017-05-19 | 2020-07-16 | メモリアル スローン ケタリング キャンサー センター | タンパク質の小胞体プロセッシングを改変する方法 |
JP7292434B2 (ja) * | 2020-01-21 | 2023-06-16 | 株式会社エビデント | 赤血球分化モニタリング装置および赤血球分化モニタリング方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4028404A (en) * | 1967-07-31 | 1977-06-07 | Allen & Hanburys Limited | Acetic acid derivatives |
US3998966A (en) * | 1971-11-04 | 1976-12-21 | Syntex Corporation | Anti-inflammatory, analgesic, anti-pyretic and anti-pruritic 6-substituted 2-naphthyl acetic acid derivative-containing compositions and methods of use thereof |
CH576447A5 (xx) * | 1972-03-10 | 1976-06-15 | Ciba Geigy Ag | |
CS181686B2 (en) * | 1974-01-14 | 1978-03-31 | Isf Spa | Process for preparing 4-cyclopropylmethylenoxy-3-chlorphenylacetic acid |
GB1511645A (en) * | 1974-05-31 | 1978-05-24 | Univ Ife | Sickle cell anaemia treatment |
US4137309A (en) * | 1976-10-14 | 1979-01-30 | The Procter & Gamble Company | Therapeutic treatment |
US4282214A (en) * | 1978-07-31 | 1981-08-04 | The Procter & Gamble Company | Phenylacetate anti-inflammatory composition |
JPS57193437A (en) * | 1981-05-21 | 1982-11-27 | Ajinomoto Co Inc | Amino acid derivative |
US4470970A (en) * | 1981-07-02 | 1984-09-11 | Burzynski Stanislaw R | Purified antineoplaston fractions and methods of treating neoplastic disease |
JPS58194814A (ja) * | 1982-05-11 | 1983-11-12 | Nippon Shinyaku Co Ltd | 免疫調節作用を有する薬剤 |
US4457942A (en) * | 1982-08-20 | 1984-07-03 | Brusilow Saul W | Process for waste nitrogen removal |
IT1170238B (it) * | 1982-12-06 | 1987-06-03 | Upjohn Co | Impiego di ibuprofene e flurbiprofene nella cura dell'erpete |
US4851404A (en) * | 1983-07-05 | 1989-07-25 | Miles Inc. | Method of treating hemoglobinopathy |
US4822821A (en) * | 1986-10-10 | 1989-04-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
US5025029A (en) * | 1986-10-10 | 1991-06-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
JPH02207021A (ja) * | 1989-02-07 | 1990-08-16 | Ono Pharmaceut Co Ltd | グアニジノ安息香酸誘導体を有効成分として含有する抗レトロウイルス剤 |
US5254587A (en) * | 1990-09-04 | 1993-10-19 | Burzynski Stanislaw R | Methods for treating AIDS |
-
1991
- 1991-10-21 US US07/779,744 patent/US6037376A/en not_active Expired - Fee Related
-
1992
- 1992-10-13 DK DK04015995T patent/DK1484059T3/da active
- 1992-10-13 EP EP20000126981 patent/EP1108428A3/en not_active Withdrawn
- 1992-10-13 DE DE69232426T patent/DE69232426T2/de not_active Expired - Lifetime
- 1992-10-13 DE DE69233743T patent/DE69233743D1/de not_active Expired - Lifetime
- 1992-10-13 AT AT92922550T patent/ATE213409T1/de not_active IP Right Cessation
- 1992-10-13 ES ES92922550T patent/ES2171400T3/es not_active Expired - Lifetime
- 1992-10-13 DE DE69233754T patent/DE69233754D1/de not_active Expired - Lifetime
- 1992-10-13 EP EP00126980A patent/EP1108427A3/en not_active Withdrawn
- 1992-10-13 ES ES04015995T patent/ES2312884T3/es not_active Expired - Lifetime
- 1992-10-13 EP EP04015995A patent/EP1484059B1/en not_active Expired - Lifetime
- 1992-10-13 AT AT04015995T patent/ATE406883T1/de not_active IP Right Cessation
- 1992-10-13 EP EP04015994A patent/EP1484058B1/en not_active Expired - Lifetime
- 1992-10-13 AT AT04015994T patent/ATE418975T1/de not_active IP Right Cessation
- 1992-10-20 IL IL103471A patent/IL103471A0/xx unknown
- 1992-10-21 NZ NZ244850A patent/NZ244850A/en not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/484,817 patent/US5877213A/en not_active Expired - Fee Related
-
2005
- 2005-01-04 HK HK05100026A patent/HK1067551A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE418975T1 (de) | 2009-01-15 |
US6037376A (en) | 2000-03-14 |
DE69233754D1 (de) | 2009-02-12 |
EP1108427A3 (en) | 2004-01-07 |
DK1484059T3 (da) | 2008-12-01 |
DE69232426T2 (de) | 2002-10-10 |
EP1484058A3 (en) | 2005-04-27 |
EP1484058B1 (en) | 2008-12-31 |
ES2171400T3 (es) | 2002-09-16 |
NZ244850A (en) | 1997-01-29 |
EP1108427A2 (en) | 2001-06-20 |
ES2312884T3 (es) | 2009-03-01 |
EP1484058A2 (en) | 2004-12-08 |
EP1108428A3 (en) | 2004-01-07 |
ATE406883T1 (de) | 2008-09-15 |
EP1108428A2 (en) | 2001-06-20 |
HK1067551A1 (en) | 2005-04-15 |
ATE213409T1 (de) | 2002-03-15 |
US5877213A (en) | 1999-03-02 |
DE69232426D1 (de) | 2002-03-28 |
EP1484059A3 (en) | 2005-04-20 |
EP1108428A9 (en) | 2001-10-31 |
EP1484059B1 (en) | 2008-09-03 |
DE69233743D1 (de) | 2008-10-16 |
EP1484059A2 (en) | 2004-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103471A0 (en) | Compositions and methods for therapy and prevention of cancer,aids and anemia | |
IL97049A0 (en) | Aryl-and heteroarylethenylene derivatives,their preparation and pharmaceutical compositions containing them | |
RU2088589C1 (en) | Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4 | |
AU2418692A (en) | New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them | |
IL101839A0 (en) | Peptide compounds,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
IL86080A0 (en) | Bicyclic compounds,processes for preparation thereof and pharmaceutical composition comprising the same | |
AU560980B2 (en) | New vitro alphatic compounds | |
CA2317673A1 (en) | Novel allylthiopyridazine derivatives and process for preparing the same | |
GR3023444T3 (en) | Nitrogen containing bicyclic derivatives, method for their preparation and pharmaceutical compositions containing them | |
PL286188A1 (en) | Method of obtaining renine retarding aminooligohydroxy derivatives | |
TW275629B (xx) | ||
MY109729A (en) | Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same | |
ZA905924B (en) | N-(23-vincristinoyl)and n-(5'-noranhydro-23-vinblastinyol)derivatives of 1-aminomethylphosphonic acid,process for preparing these and pharmaceutical compositions containing them | |
ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
GB8801899D0 (en) | Antibiotic a42867 derivative | |
DE3162410D1 (en) | Bis-(substituted phenoxyacetates) of n-alkyl-dialkanol amines, process for their preparation, and pharmaceutical compositions containing them |